Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
US8604054B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 22, 2011 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Dec 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a triglyceride-lowering agent, exhibiting excellent triglyceride-lowering effect and a hyperinsulinemia-ameliorating agent.The triglyceride-lowering agent and hyperinsulinemia-ameliorating agent are characterized by containing a pitavastatin compound, and amlodipine or a salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.